SwePub
Sök i LIBRIS databas

  Extended search

(WFRF:(Giedraitis Vilmantas)) pers:(Ingelsson Erik)
 

Search: (WFRF:(Giedraitis Vilmantas)) pers:(Ingelsson Erik) > (2008-2009) > Plasma β Amyloid an...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Plasma β Amyloid and the Risk of Alzheimer Disease and Dementia in Elderly Men : A Prospective, Population-Based Cohort Study

Sundelöf, Johan (author)
Uppsala universitet,Geriatrik
Giedraitis, Vilmantas (author)
Uppsala universitet,Geriatrik
Irizarry, Michael C (author)
show more...
Sundström, Johan (author)
Uppsala universitet,Institutionen för medicinska vetenskaper,Geriatrik
Ingelsson, Erik (author)
Uppsala universitet,Geriatrik
Rönnemaa, Elina (author)
Uppsala universitet,Geriatrik
Arnlöv, Johan (author)
Högskolan Dalarna,Uppsala universitet,Geriatrik,Medicinsk vetenskap
Gunnarsson, Malin Degerman (author)
Uppsala universitet,Geriatrik
Hyman, Bradley T (author)
Basun, Hans (author)
Uppsala universitet,Geriatrik
Ingelsson, Martin (author)
Uppsala universitet,Geriatrik
Lannfelt, Lars (author)
Uppsala universitet,Geriatrik
Kilander, Lena (author)
Uppsala universitet,Geriatrik
show less...
 (creator_code:org_t)
American Medical Association (AMA), 2008
2008
English.
In: Archives of Neurology. - : American Medical Association (AMA). - 0003-9942 .- 1538-3687. ; 65:2, s. 256-63
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • BACKGROUND: Beta amyloid (Abeta) protein accumulates in the brains of individuals with Alzheimer disease (AD) and is detectable in cerebrospinal fluid and plasma. OBJECTIVE: To examine plasma levels of Abeta peptides Abeta(40) and Abeta(42) as predictors of incident AD and other types of dementia. DESIGN: Prospective, population-based cohort study. SETTING: The Uppsala Longitudinal Study of Adult Men. PARTICIPANTS: Plasma Abeta(40) and Abeta(42) levels were analyzed as predictors of incident AD in 1045 men at age 70 years and 680 men at age 77 years using Cox proportional hazards analyses. Alzheimer disease and other types of dementia were diagnosed by standardized screening, clinical evaluation, and medical record review. MAIN OUTCOME MEASURES: Hazard ratios of AD (primary outcome) and vascular dementia or other dementia (secondary outcomes) according to baseline levels of plasma Abeta(40) and Abeta(42). RESULTS: From the age of 77 years at baseline, 46 individuals developed AD at follow-up (median, 5.3 years). A low plasma Abeta(40) level at age 77 years was associated with higher incidence of AD. The multivariate-adjusted hazard ratio was 4.87 (95% confidence interval, 1.63-14.6) for the lowest Abeta(40) tertile compared with the highest tertile. On follow-up from age 70 years at baseline (median, 11.2 years), 82 individuals developed AD. Plasma Abeta(40) and Abeta(42) levels measured at age 70 years were not significantly associated with incident AD. CONCLUSIONS: Low plasma Abeta(40) levels predicted incident AD in elderly men independently of potential confounders. Plasma Abeta(42) levels were not significantly associated with AD incidence. The clinical value of Abeta measurement in plasma remains to be established in future studies.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)

Keyword

MEDICINE
MEDICIN
Hälsa och välfärd

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view